Hector, A.* ; Kormann, M.* ; Kammermeier, J.* ; Burdi, S.* ; Marcos, V.* ; Rieber, N.* ; Mays, L.* ; Illig, T. ; Klopp, N. ; Falkenstein, F.* ; Kappler, M.* ; Riethmueller, J.* ; Graepler-Mainka, U.* ; Stern, M.* ; Eickmeier, O.* ; Serve, F.* ; Zielen, S.* ; Döring, G.* ; Griese, M.* ; Hartl, D.*
Expression and regulation of interferon-related development regulator-1 in cystic fibrosis neutrophils.
Am. J. Respir. Cell Mol. Biol. 48, 71-77 (2013)
A genome-wide association study identified interferon-related development regulator-1 (IFRD1), a protein expressed by neutrophils, as a key modifier gene in cystic fibrosis (CF) lung disease. Here, we investigated the expression and regulation of IFRD1 in CF neutrophils. IFRD1 expression was quantified in peripheral blood and airway neutrophils from patients with CF, patients with non-CF lung disease, and healthy control subjects. The regulation of IFRD1 expression was analyzed using isolated neutrophils and ex vivo stimulation assays with CF airway fluids. IFRD1 single-nucleotide polymorphisms (SNPs) were analyzed in a CF cohort (n = 572) and correlated with longitudinal lung function and IFRD1 expression. Patients with CF expressed higher protein levels of IFRD1 in peripheral blood neutrophils compared with healthy or non-CF disease control subjects. Within patients with CF, IFRD1 protein expression levels in neutrophils were lower in airway fluids compared with peripheral blood. High IFRD1 expression was positively associated with the production of reactive oxygen species (ROS) in CF neutrophils. In vitro regulation studies showed that CF airway fluid and the CF-characteristic chemokines CXCL8 and CXCL2 down-regulated IFRD1 expression in neutrophils, an effect that was mediated through CXCR2. Genetic analyses showed that three IFRD1 SNPs were associated with longitudinal declines in lung function, and modulated IFRD1 expression. These studies demonstrate that IFRD1 expression is systemically up-regulated in human CF neutrophils, is linked to the production of ROS, and is modulated by chemokines in CF airway fluids, depending on the IFRD1 genotype. Understanding the regulation of IFRD1 may pave the way for novel therapeutic approaches to target neutrophilic inflammation in CF.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Neutrophils ; Ifrd1 ; Cystic Fibrosis ; Inflammation ; Innate Immunity; Lung-disease Severity ; Nerve Growth-factor ; Pc12 Cells ; Genotype ; Genes ; Differentiation ; Inflammation ; Induction ; Phenotype ; Modifiers
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2013
Prepublished im Jahr
HGF-Berichtsjahr
2013
ISSN (print) / ISBN
1044-1549
e-ISSN
1535-4989
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 48,
Heft: 1,
Seiten: 71-77
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Thoracic Society
Verlagsort
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-504200-001
Förderungen
Copyright
Erfassungsdatum
2013-02-04